| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Revenue | $5.7B | $5.7B | $4.5B | $2.3B |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| R&D Expense | — | — | — | — |
| SG&A Expense | — | — | — | — |
| Operating Income | — | — | — | — |
| Net Income | $0.3B | $0.6B | $-0.1B | $0.5B |
| EPS (Basic) | $1.89 | $4.98 | $-0.47 | $4.18 |
| EPS (Diluted) | $1.88 | $4.88 | $-0.47 | $4.18 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Total Assets | $98.4B | $85.0B | $70.2B | $55.1B |
| Current Assets | — | — | — | — |
| Cash & Equivalents | $1.5B | $2.3B | $1.6B | $1.0B |
| Total Liabilities | $93.5B | $81.0B | $67.1B | $53.3B |
| Current Liabilities | — | — | — | — |
| Stockholders' Equity | $4.8B | $4.0B | $3.1B | $1.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Operating Cash Flow | $4.7B | $6.0B | $5.8B | $3.2B |
| Investing Cash Flow | $-8.4B | $-8.0B | $-8.9B | $-9.4B |
| Capital Expenditures | — | — | — | — |
| Financing Cash Flow | $3.0B | $2.7B | $3.7B | $5.6B |